An Australian-led trial found a personalised mRNA vaccine reduced melanoma recurrence or death by 42 per cent when combined with pembrolizumabHealthOct 22 at 6:59 PM – Oct 22 at 11:11 PM3 outletsNewshubIt’s being called a landmark moment in cancer treatment and it’s got scientists very ‘excited’ Oct 22 at 9:50 PMThe Sydney Morning Herald‘Landmark moment’: Sydney scientist’s world-first cancer breakthrough revealed Oct 22 at 6:59 PMPerthNowAussie researcher's international cancer breakthrough Oct 22 at 11:11 PM